United States In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Published : Dec-2017

No. of Pages : 2729

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 19
2 Introduction 24
2.1 What Is This Report About? 24
2.2 In Vitro Diagnostics (IVD) Market Segmentation 24
2.3 Definitions of Markets Covered in the Report 28
3 In Vitro Diagnostics Market, United States 51
3.1 In Vitro Diagnostics Market, United States, Revenue ($m), 2010-2024 51
3.2 In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2017 53
3.3 In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2017 54
3.4 In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), 2009-2023 56
3.5 In Vitro Diagnostics Market, United States, Revenue ($m), 2010-2017 58
3.6 In Vitro Diagnostics Market, United States, Revenue ($m), 2017-2024 60
3.7 In Vitro Diagnostics Market, United States, Volume (Units), 2010-2024 62
3.8 In Vitro Diagnostics Market, United States, Volume (Units), 2010-2017 64
3.9 In Vitro Diagnostics Market, United States, Volume (Units), 2017-2024 66
3.10 In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), 2017 68
4 Clinical Chemistry Market, United States 70
4.1 Clinical Chemistry Market, United States, Revenue Mix ($m), 2017 70
4.2 Clinical Chemistry Market, United States, Segment Contribution (%), 2017 71
4.3 Clinical Chemistry Market, United States, Revenue ($m), 2010-2017 73
4.4 Clinical Chemistry Market, United States, Revenue ($m), 2017-2024 75
4.5 Clinical Chemistry Market, United States, Volume (Units), 2010-2017 109
4.6 Clinical Chemistry Market, United States, Volume (Units), 2017-2024 111
4.7 Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), 2017 137
4.8 Clinical Chemistry Market, United States, Company Share by Revenue ($m), 2017 138
5 Genetic Testing Market, United States 140
5.1 Genetic Testing Market, United States, Revenue Mix ($m), 2017 140
5.2 Genetic Testing Market, United States, Segment Contribution (%), 2017 141
5.3 Genetic Testing Market, United States, Revenue ($m), 2010-2017 142
5.4 Genetic Testing Market, United States, Revenue ($m), 2017-2024 144
5.5 Genetic Testing Market, United States, Distribution Share by Revenue ($m), 2017 146
5.6 Genetic Testing Market, United States, Company Share by Revenue ($m), 2017 147
6 Hematology Market, United States 149
6.1 Hematology Market, United States, Revenue Mix ($m), 2017 149
6.2 Hematology Market, United States, Segment Contribution (%), 2017 150
6.3 Hematology Market, United States, Revenue ($m), 2010-2017 152
6.4 Hematology Market, United States, Revenue ($m), 2017-2024 154
6.5 Hematology Market, United States, Volume (Units), 2010-2017 180
6.6 Hematology Market, United States, Volume (Units), 2017-2024 182
6.7 Hematology Market, United States, Distribution Share by Revenue ($m), 2017 200
6.8 Hematology Market, United States, Company Share by Revenue ($m), 2017 201
7 Histology And Cytology Market, United States 203
7.1 Histology And Cytology Market, United States, Revenue Mix ($m), 2017 203
7.2 Histology And Cytology Market, United States, Segment Contribution (%), 2017 204
7.3 Histology And Cytology Market, United States, Revenue ($m), 2010-2017 206
7.4 Histology And Cytology Market, United States, Revenue ($m), 2017-2024 208
7.5 Histology And Cytology Market, United States, Distribution Share by Revenue ($m), 2017 210
7.6 Histology And Cytology Market, United States, Company Share by Revenue ($m), 2017 211
8 Immuno Chemistry Market, United States 213
8.1 Immuno Chemistry Market, United States, Revenue Mix ($m), 2017 213
8.2 Immuno Chemistry Market, United States, Segment Contribution (%), 2017 214
8.3 Immuno Chemistry Market, United States, Revenue ($m), 2010-2017 216
8.4 Immuno Chemistry Market, United States, Revenue ($m), 2017-2024 218
8.5 Immuno Chemistry Market, United States, Volume (Units), 2010-2017 252
8.6 Immuno Chemistry Market, United States, Volume (Units), 2017-2024 254
8.7 Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), 2017 288
8.8 Immuno Chemistry Market, United States, Company Share by Revenue ($m), 2017 289
9 Infectious Diagnostics Market, United States 291
9.1 Infectious Diagnostics Market, United States, Revenue Mix ($m), 2017 291
9.2 Infectious Diagnostics Market, United States, Segment Contribution (%), 2017 292
9.3 Infectious Diagnostics Market, United States, Revenue ($m), 2010-2017 294
9.4 Infectious Diagnostics Market, United States, Revenue ($m), 2017-2024 297
9.5 Infectious Diagnostics Market, United States, Volume (Units), 2010-2017 344
9.6 Infectious Diagnostics Market, United States, Volume (Units), 2017-2024 347
9.7 Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), 2017 396
9.8 Infectious Diagnostics Market, United States, Company Share by Revenue ($m), 2017 397
10 Microbiology Culture Market, United States 399
10.1 Microbiology Culture Market, United States, Revenue Mix ($m), 2017 399
10.2 Microbiology Culture Market, United States, Segment Contribution (%), 2017 400
10.3 Microbiology Culture Market, United States, Revenue ($m), 2010-2017 402
10.4 Microbiology Culture Market, United States, Revenue ($m), 2017-2024 404
10.5 Microbiology Culture Market, United States, Distribution Share by Revenue ($m), 2017 414
10.6 Microbiology Culture Market, United States, Company Share by Revenue ($m), 2017 415
11 Overview of Key Companies in United States, In Vitro Diagnostics Market 417
11.1 F. Hoffmann-La Roche Ltd 417
11.2 Beckman Coulter Inc 417
11.3 Abbott Laboratories 417
11.4 Becton Dickinson and Co 417
11.5 Siemens Healthcare GmbH 418
11.6 Thermo Fisher Scientific Inc 418
11.7 Hologic Inc 418
11.8 Sysmex Corp 419
11.9 bioMerieux SA 419
11.10 Ortho-Clinical Diagnostics Inc 419
11.11 Bio-Rad Laboratories Inc 419
11.12 Qiagen NV 420
11.13 Alere Inc 420
11.14 DiaSorin S.p.A 420
12 In Vitro Diagnostics Market Pipeline Products 421
13 Financial Deals Landscape 425
13.1 Acquisition 425
13.2 Asset Transactions 461
13.3 Debt Offerings 477
13.4 Equity Offerings 587
13.5 Merger 744
13.6 Partnerships 747
13.7 Private Equity 925
13.8 Venture Financing 936
14 Recent Developments 1084
14.1 Corporate Communications 1084
14.2 Financial Announcements 1356
14.3 Government and Public Interest 2168
14.4 Legal And Regulatory 2192
14.5 Other Significant Developments 2229
14.6 Product News 2367
14.7 Research And Development 2618
14.8 Strategy And Business Planning 2619
15 Appendix 2656
15.1 Research Methodology 2657
15.2 GlobalData Consulting 2661
15.3 Contact Us 2662
15.4 Disclaimer 2662

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2010-2024 119
Table 2: In Vitro Diagnostics Market, United States, Category Contribution by Revenue ($m), 2017 122
Table 3: In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), 2009-2023 124
Table 4: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 126
Table 5: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 128
Table 6: In Vitro Diagnostics Market, United States, Volume (Units), 2010-2024 130
Table 7: In Vitro Diagnostics Market, United States, Volume (Units), Historic, 2010-2017 132
Table 8: In Vitro Diagnostics Market, United States, Volume (Units), Forecast, 2017-2024 134
Table 9: In Vitro Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2017 136
Table 10: Clinical Chemistry Market, United States, Segment Contribution (%), 2017 139
Table 11: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 141
Table 12: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 143
Table 13: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 145
Table 14: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 147
Table 15: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 149
Table 16: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 151
Table 17: Substrates Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 153
Table 18: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 155
Table 19: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 157
Table 20: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 159
Table 21: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 161
Table 22: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 163
Table 23: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 165
Table 24: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 167
Table 25: Substrates Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 169
Table 26: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 171
Table 27: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 173
Table 28: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 175
Table 29: Clinical Chemistry Market, United States, Volume (Units), Historic, 2010-2017 177
Table 30: Clinical Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 179
Table 31: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 181
Table 32: Clinical Chemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 183
Table 33: Enzyme Chemistry Reagents Market, United States, Volume (Units), Historic, 2010-2017 185
Table 34: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 187
Table 35: Substrates Market, United States, Volume (Units), Historic, 2010-2017 189
Table 36: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 191
Table 37: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 193
Table 38: Clinical Chemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 195
Table 39: Enzyme Chemistry Reagents Market, United States, Volume (Units), Forecast, 2017-2024 197
Table 40: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 199
Table 41: Substrates Market, United States, Volume (Units), Forecast, 2017-2024 201
Table 42: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 203
Table 43: Clinical Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016-2017 204
Table 44: Clinical Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2017 206
Table 45: Genetic Testing Market, United States, Segment Contribution (%), 2017 208
Table 46: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 210
Table 47: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 212
Table 48: Genetic Testing Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 213
Table 49: Genetic Testing Market, United States, Company Share by Revenue ($m), USD Constant, 2017 215
Table 50: Hematology Market, United States, Segment Contribution (%), 2017 218
Table 51: Hematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 220
Table 52: Hematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 222
Table 53: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 224
Table 54: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 226
Table 55: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 228
Table 56: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 230
Table 57: Hemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 232
Table 58: Immunohematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 234
Table 59: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 236
Table 60: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 238
Table 61: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 240
Table 62: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 242
Table 63: Hemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 244
Table 64: Immunohematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 246
Table 65: Hematology Market, United States, Volume (Units), Historic, 2010-2017 248
Table 66: Hematology Market, United States, Volume (Units), Forecast, 2017-2024 250
Table 67: Hematology Analyzers Market, United States, Volume (Units), Historic, 2010-2017 252
Table 68: Hematology Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 254
Table 69: Hematology Reagents Market, United States, Volume (Units), Historic, 2010-2017 256
Table 70: Hemostasis Market, United States, Volume (Units), Historic, 2010-2017 258
Table 71: Hematology Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 260
Table 72: Hematology Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 262
Table 73: Hematology Reagents Market, United States, Volume (Units), Forecast, 2017-2024 264
Table 74: Hemostasis Market, United States, Volume (Units), Forecast, 2017-2024 266
Table 75: Hematology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 267
Table 76: Hematology Market, United States, Company Share by Revenue ($m), USD Constant, 2017 269
Table 77: Histology And Cytology Market, United States, Segment Contribution (%), 2017 272
Table 78: Histology And Cytology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 274
Table 79: Histology And Cytology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 276
Table 80: Histology And Cytology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 277
Table 81: Histology And Cytology Market, United States, Company Share by Revenue ($m), USD Constant, 2017 279
Table 82: Immuno Chemistry Market, United States, Segment Contribution (%), 2017 282
Table 83: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 284
Table 84: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 286
Table 85: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 288
Table 86: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 290
Table 87: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 292
Table 88: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 294
Table 89: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 296
Table 90: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 298
Table 91: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 300
Table 92: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 302
Table 93: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 304
Table 94: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 306
Table 95: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 308
Table 96: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 310
Table 97: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 312
Table 98: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 314
Table 99: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 316
Table 100: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 318
Table 101: Immuno Chemistry Market, United States, Volume (Units), Historic, 2010-2017 320
Table 102: Immuno Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 322
Table 103: Complement Deficiency Tests Market, United States, Volume (Units), Historic, 2010-2017 324
Table 104: Diabetes Assays Market, United States, Volume (Units), Historic, 2010-2017 326
Table 105: Disease Specific Immunochemistry Market, United States, Volume (Units), Historic, 2010-2017 328
Table 106: Endocrinology Tests Market, United States, Volume (Units), Historic, 2010-2017 330
Table 107: IgE Allergy Blood Tests Market, United States, Volume (Units), Historic, 2010-2017 332
Table 108: Immunochemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 334
Table 109: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 336
Table 110: Vitamins Tests Market, United States, Volume (Units), Historic, 2010-2017 338
Table 111: Complement Deficiency Tests Market, United States, Volume (Units), Forecast, 2017-2024 340
Table 112: Diabetes Assays Market, United States, Volume (Units), Forecast, 2017-2024 342
Table 113: Disease Specific Immunochemistry Market, United States, Volume (Units), Forecast, 2017-2024 344
Table 114: Endocrinology Tests Market, United States, Volume (Units), Forecast, 2017-2024 346
Table 115: IgE Allergy Blood Tests Market, United States, Volume (Units), Forecast, 2017-2024 348
Table 116: Immunochemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 350
Table 117: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 352
Table 118: Vitamins Tests Market, United States, Volume (Units), Forecast, 2017-2024 354
Table 119: Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 355
Table 120: Immuno Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2017 357
Table 121: Infectious Diagnostics Market, United States, Segment Contribution (%), 2017 360
Table 122: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 362
Table 123: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 365
Table 124: Chlamydia trichomatis Diagnostic Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 368
Table 125: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 370
Table 126: Hepatitis Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 372
Table 127: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 374
Table 128: Infectious Diagnostics Multiple Parameter Test Kits Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 376
Table 129: Infectious Diagnostics Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 378
Table 130: Mycobacterium tuberculosis Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 380
Table 131: Polymerase Chain Reaction (PCR) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 382
Table 132: Post Streptococcus pyogenes Diagnostic Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 384
Table 133: Retrovirus Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 386

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, 2010-2024 118
Figure 2: In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2017 120
Figure 3: In Vitro Diagnostics Market, United States, Category Contribution (%), 2017 121
Figure 4: In Vitro Diagnostics Market, United States, Category Comparison by Revenue ($m), 2009-2023 123
Figure 5: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 125
Figure 6: In Vitro Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 127
Figure 7: In Vitro Diagnostics Market, United States, Volume (Units), 2010-2024 129
Figure 8: In Vitro Diagnostics Market, United States, Volume (Units), Historic, 2010-2017 131
Figure 9: In Vitro Diagnostics Market, United States, Volume (Units), Forecast, 2017-2024 133
Figure 10: In Vitro Diagnostics Market, United States, Company Share (%) 2017 135
Figure 11: Clinical Chemistry Market, United States, Revenue Mix ($m), 2017 137
Figure 12: Clinical Chemistry Market, United States, Segment Contribution (%), 2017 138
Figure 13: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 140
Figure 14: Clinical Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 142
Figure 15: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 144
Figure 16: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 146
Figure 17: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 148
Figure 18: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 150
Figure 19: Substrates Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 152
Figure 20: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 154
Figure 21: Urine Analysis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 156
Figure 22: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 158
Figure 23: Blood Test Strips - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 160
Figure 24: Clinical Chemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 162
Figure 25: Enzyme Chemistry Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 164
Figure 26: Feces Tests - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 166
Figure 27: Substrates Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 168
Figure 28: Therapeutic Drug Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 170
Figure 29: Urine Analysis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 172
Figure 30: Urine Testing - Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 174
Figure 31: Clinical Chemistry Market, United States, Volume (Units), Historic, 2010-2017 176
Figure 32: Clinical Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 178
Figure 33: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 180
Figure 34: Clinical Chemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 182
Figure 35: Enzyme Chemistry Reagents Market, United States, Volume (Units), Historic, 2010-2017 184
Figure 36: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 186
Figure 37: Substrates Market, United States, Volume (Units), Historic, 2010-2017 188
Figure 38: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 190
Figure 39: Blood Test Strips - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 192
Figure 40: Clinical Chemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 194
Figure 41: Enzyme Chemistry Reagents Market, United States, Volume (Units), Forecast, 2017-2024 196
Figure 42: Feces Tests - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 198
Figure 43: Substrates Market, United States, Volume (Units), Forecast, 2017-2024 200
Figure 44: Urine Testing - Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 202
Figure 45: Clinical Chemistry Market, United States, Company Share (%) 2017 205
Figure 46: Genetic Testing Market, United States, Revenue Mix ($m), 2017 207
Figure 47: Genetic Testing Market, United States, Segment Contribution (%), 2017 208
Figure 48: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 209
Figure 49: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 211
Figure 50: Genetic Testing Market, United States, Company Share (%) 2017 214
Figure 51: Hematology Market, United States, Revenue Mix ($m), 2017 216
Figure 52: Hematology Market, United States, Segment Contribution (%), 2017 217
Figure 53: Hematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 219
Figure 54: Hematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 221
Figure 55: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 223
Figure 56: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 225
Figure 57: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 227
Figure 58: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 229
Figure 59: Hemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 231
Figure 60: Immunohematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 233
Figure 61: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 235
Figure 62: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 237
Figure 63: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 239
Figure 64: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 241
Figure 65: Hemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 243
Figure 66: Immunohematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 245
Figure 67: Hematology Market, United States, Volume (Units), Historic, 2010-2017 247
Figure 68: Hematology Market, United States, Volume (Units), Forecast, 2017-2024 249
Figure 69: Hematology Analyzers Market, United States, Volume (Units), Historic, 2010-2017 251
Figure 70: Hematology Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 253
Figure 71: Hematology Reagents Market, United States, Volume (Units), Historic, 2010-2017 255
Figure 72: Hemostasis Market, United States, Volume (Units), Historic, 2010-2017 257
Figure 73: Hematology Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 259
Figure 74: Hematology Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 261
Figure 75: Hematology Reagents Market, United States, Volume (Units), Forecast, 2017-2024 263
Figure 76: Hemostasis Market, United States, Volume (Units), Forecast, 2017-2024 265
Figure 77: Hematology Market, United States, Company Share (%) 2017 268
Figure 78: Histology And Cytology Market, United States, Revenue Mix ($m), 2017 270
Figure 79: Histology And Cytology Market, United States, Segment Contribution (%), 2017 271
Figure 80: Histology And Cytology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 273
Figure 81: Histology And Cytology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 275
Figure 82: Histology And Cytology Market, United States, Company Share (%) 2017 278
Figure 83: Immuno Chemistry Market, United States, Revenue Mix ($m), 2017 280
Figure 84: Immuno Chemistry Market, United States, Segment Contribution (%), 2017 281
Figure 85: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 283
Figure 86: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 285
Figure 87: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 287
Figure 88: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 289
Figure 89: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 291
Figure 90: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 293
Figure 91: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 295
Figure 92: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 297
Figure 93: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 299
Figure 94: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 301
Figure 95: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 303
Figure 96: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 305
Figure 97: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 307
Figure 98: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 309
Figure 99: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 311
Figure 100: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 313
Figure 101: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 315
Figure 102: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 317
Figure 103: Immuno Chemistry Market, United States, Volume (Units), Historic, 2010-2017 319
Figure 104: Immuno Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 321
Figure 105: Complement Deficiency Tests Market, United States, Volume (Units), Historic, 2010-2017 323
Figure 106: Diabetes Assays Market, United States, Volume (Units), Historic, 2010-2017 325
Figure 107: Disease Specific Immunochemistry Market, United States, Volume (Units), Historic, 2010-2017 327
Figure 108: Endocrinology Tests Market, United States, Volume (Units), Historic, 2010-2017 329
Figure 109: IgE Allergy Blood Tests Market, United States, Volume (Units), Historic, 2010-2017 331
Figure 110: Immunochemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 333
Figure 111: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 335
Figure 112: Vitamins Tests Market, United States, Volume (Units), Historic, 2010-2017 337
Figure 113: Complement Deficiency Tests Market, United States, Volume (Units), Forecast, 2017-2024 339
Figure 114: Diabetes Assays Market, United States, Volume (Units), Forecast, 2017-2024 341
Figure 115: Disease Specific Immunochemistry Market, United Stat

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500

United States In Vitro Diagnostics (IVD) Market Outlook to 2024 - Clinical Chemistry, Genetic Testing, Hematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model